(Q37961883)

26 August 2017

title

Lipids and diabetic retinopathy (English)

1 reference

26 August 2017

0 references

Laurence S Lim

1

1 reference

26 August 2017

Tien Y Wong

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

28 November 2011

1 reference

Expert Opinion on Biological Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

93-105

1 reference

Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Management of diabetic retinopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The prevalence of diabetic retinopathy among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Diabetic retinopathy in Mexican Americans and non-Hispanic whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Further survey of Australian ophthalmologist's diabetic retinopathy management: did practice adhere to National Health and Medical Research Council guidelines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Advances in the medical treatment of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Diabetic retinopathy in a multi-ethnic cohort in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The prevalence of and factors associated with diabetic retinopathy in the Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Plasma-lipids and glucose/insulin relationship in non-insulin-requiring diabetics with and without retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipid profiles and blood pressure: are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin-dependent diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Serum lipid profile in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Prevalence of diabetic retinopathy in Tehran province: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

21 January 2018

Obesity and eye diseases

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The pathogenesis of edema in diabetic maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

AGEs and diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Increased Retinal Lipid Peroxidation in Early Diabetes is not Associated with Ascorbate Depletion or Changes in Ascorbate Redox State

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Oxidative Stress and Diabetic Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Protein phosphorylation in pancreatic islets: evidence for separate Ca2+ and cAMP-enhanced phosphorylation of two 57,000 Mr proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Retinal neurodegeneration: early pathology in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein (a) and stroke: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein[a] as a risk factor for preclinical atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The association of hyperlipidemia with retinopathy in diabetic patients aged 15-50 years in the county of Umeå.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipids and lipoproteins in diabetic adolescents and young adults with retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein(a) is a risk factor for diabetic retinopathy in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein(a) as an independent risk factor for diabetic retinopathy in male patients in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoproteins and diabetic microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Lipoprotein(a) in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Apolipoprotein A1 is overexpressed in the retina of diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Cholesterol and cardiovascular disease. An overview of Lipid Research Clinics (LRC) epidemiologic studies as background for the LRC Coronary Primary Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Intraretinal leakage and oxidation of LDL in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Use of fibrates in the United States and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Rosiglitazone and delayed onset of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Diabetic macular edema associated with glitazone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Glitazone use associated with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Frequency of fish consumption, retinal microvascular signs and vascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.641531

10.1517/14712598.2012.641531

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference